These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 17506033)

  • 1. Activities of erythropoietin on tumors: an immunological perspective.
    Ghezzi P; Mengozzi M
    Eur J Immunol; 2007 Jun; 37(6):1427-30. PubMed ID: 17506033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythropoietin enhances immune responses in mice.
    Katz O; Gil L; Lifshitz L; Prutchi-Sagiv S; Gassmann M; Mittelman M; Neumann D
    Eur J Immunol; 2007 Jun; 37(6):1584-93. PubMed ID: 17458859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythropoietin protects critically perfused flap tissue.
    Rezaeian F; Wettstein R; Amon M; Scheuer C; Schramm R; Menger MD; Pittet B; Harder Y
    Ann Surg; 2008 Dec; 248(6):919-29. PubMed ID: 19092336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythropoietin and the nervous system.
    Genc S; Koroglu TF; Genc K
    Brain Res; 2004 Mar; 1000(1-2):19-31. PubMed ID: 15053948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant human erythropoietin reduces epithelial cell apoptosis and attenuates bleomycin-induced pneumonitis in mice.
    Yoshimi M; Maeyama T; Yamada M; Hamada N; Fukumoto J; Kawaguchi T; Kuwano K; Nakanishi Y
    Respirology; 2008 Sep; 13(5):639-45. PubMed ID: 18713087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel renoprotective actions of erythropoietin: new uses for an old hormone.
    Johnson DW; Forman C; Vesey DA
    Nephrology (Carlton); 2006 Aug; 11(4):306-12. PubMed ID: 16889570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythropoietin induces tumor regression and antitumor immune responses in murine myeloma models.
    Mittelman M; Neumann D; Peled A; Kanter P; Haran-Ghera N
    Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5181-6. PubMed ID: 11309490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-erythropoietic tissue-protective peptides derived from erythropoietin: WO2009094172.
    Dumont F; Bischoff P
    Expert Opin Ther Pat; 2010 May; 20(5):715-23. PubMed ID: 20192905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythropoietin reduces necrosis in critically ischemic myocutaneous tissue by protecting nutritive perfusion in a dose-dependent manner.
    Harder Y; Amon M; Schramm R; Contaldo C; Metzkow E; Matzen A; Rücker M; Vollmar B; Menger MD
    Surgery; 2009 Apr; 145(4):372-83. PubMed ID: 19303985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of erythropoietin receptor and in vitro functional effects of epoetins in B-cell malignancies.
    Kokhaei P; Abdalla AO; Hansson L; Mikaelsson E; Kubbies M; Haselbeck A; Jernberg-Wiklund H; Mellstedt H; Osterborg A
    Clin Cancer Res; 2007 Jun; 13(12):3536-44. PubMed ID: 17575216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythropoietin in cancer: the new face of an old friend.
    Megalakaki C
    J BUON; 2008; 13(1):7-16. PubMed ID: 18404780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythropoietin and its non-erythropoietic derivative: do they ameliorate renal tubulointerstitial injury in ureteral obstruction?
    Srisawat N; Manotham K; Eiam-Ong S; Katavetin P; Praditpornsilpa K; Eiam-Ong S
    Int J Urol; 2008 Oct; 15(11):1011-7. PubMed ID: 18759748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glioblastoma multiforme cells: expression of erythropoietin receptor and response to erythropoietin.
    Yin D; Kawabata H; Tcherniamtchouk O; Huynh T; Black KL; Koeffler HP
    Int J Oncol; 2007 Nov; 31(5):1193-8. PubMed ID: 17912447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythropoietin attenuates lipopolysaccharide-induced white matter injury in the neonatal rat brain.
    Kumral A; Baskin H; Yesilirmak DC; Ergur BU; Aykan S; Genc S; Genc K; Yilmaz O; Tugyan K; Giray O; Duman N; Ozkan H
    Neonatology; 2007; 92(4):269-78. PubMed ID: 17627093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythropoietin and treatment of non-anemic conditions--cardiovascular protection.
    Fliser D; Haller H
    Semin Hematol; 2007 Jul; 44(3):212-7. PubMed ID: 17631185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection and quantification of functionally defined hematopoietic progenitor cells and tissue specific mRNA within the peripheral blood of myeloma patients after administration of granulocyte colony-stimulating factor and erythropoietin.
    Grassinger J; Mueller G; Hart C; Nilsson SK; Haylock DN; Andreesen R; Hennemann B
    Eur J Haematol; 2008 Jan; 80(1):20-30. PubMed ID: 18028434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythropoietin and carbamylated erythropoietin are neuroprotective following spinal cord hemisection in the rat.
    King VR; Averill SA; Hewazy D; Priestley JV; Torup L; Michael-Titus AT
    Eur J Neurosci; 2007 Jul; 26(1):90-100. PubMed ID: 17614942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythropoietin-mediated tissue protection: reducing collateral damage from the primary injury response.
    Brines M; Cerami A
    J Intern Med; 2008 Nov; 264(5):405-32. PubMed ID: 19017170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-erythroid effects of erythropoietin: are neutrophils a target?
    Avneon M; Lifshitz L; Katz O; Prutchi-Sagiv S; Gassmann M; Mittelman M; Neumann D
    Leuk Res; 2009 Oct; 33(10):1430-2. PubMed ID: 19376577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From the oxygen to the organ protection: erythropoietin as protagonist in internal medicine.
    Buemi M; Nostro L; Romeo A; Giacobbe MS; Aloisi C; Sturiale A; Bolignano D; Allegra A; Grasso G; Frisina N
    Cardiovasc Hematol Agents Med Chem; 2006 Oct; 4(4):299-311. PubMed ID: 17073607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.